13G Filing: Camber Capital Management and AMAG Pharmaceuticals Inc. (AMAG)

Page 6 of 6

Page 6 of 6 – SEC Filing

13G

CUSIP No.
 00163U106
Page 6 of
6
 
 
 
ITEM 10. CERTIFICATIONS.
The following
certification shall be included if the statement is filed pursuant
to S.240.13d-1(c):
By signing below I
certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any
transaction having such purpose or effect.
 
 
 
SIGNATURE
 
After reasonable
inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
 
CAMBER CAPITAL
MANAGEMENT LLC
By: /s/Sean
George
Sean
George
Chief Financial
Officer
 
STEPHEN
DUBOIS
By: /s/ Stephen
DuBois
Stephen DuBois,
individually
 
The original
statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the
statement is signed on behalf of a person by his authorized
representative other than an executive officer or general partner
of the filing person, evidence of the representative’s authority to
sign on behalf of such person shall be filed with the statement,
provided, however, that a power of attorney for this purpose which
is already on file with the Commission may be incorporated by
reference. The name and any title of each person who signs the
statement shall be typed or printed beneath his
signature.
 
 

Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)

Page 6 of 6